Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters
 

Greenwich, Connecticut Clinical Trials

A listing of Greenwich, Connecticut clinical trials actively recruiting patient volunteers.

RESULTS

Found (9) clinical trials

A Study of LY3303560 in Participants With Early Symptomatic Alzheimer's Disease

The purpose of this study is to evaluate the safety and efficacy of a study drug that targets an abnormal protein in the brain found in people with Alzheimer's Disease (AD).

Phase

5.49 miles

Learn More »

A Study to Test the Safety of Immunotherapy With Nivolumab Alone or With Ipilimumab Before Surgery for Bladder Cancer Patients Who Are Not Suitable for Chemotherapy

The purpose of this study is to test if immunotherapy with nivolumab alone or in combination with ipilimumab is safe and does not delay the planned bladder cancer surgery. The investigators want to see if treatment with these drugs prior to surgery may decrease the size of the bladder cancer ...

Phase

6.01 miles

Learn More »

Pilot Trial of the Robotic Uterine Manipulator

The purpose of this study is to test a robotic uterine manipulator system called the Barakat Automated Uterine Manipulator (BAUM), which will assist the surgeon in moving and positioning the uterus during a hysterectomy. This new device will allow the surgeon to control the movements of the robotic arm directly ...

Phase N/A

6.01 miles

Learn More »

Study of Proton Radiation to the Brain and Spinal Cord for Patients With Leptomeningeal Metastases

The purpose of this study is to find the safest and most effective dose for delivering proton beam to the space containing CSF, brain, and spinal cord, in treating leptomeningeal metastases. The researchers think that using proton beam radiation to treat the space containing CSF, brain, and spinal cord, instead ...

Phase

6.01 miles

Learn More »

Short Course Daratumumab in Patients With Multiple Myeloma

The purpose of this study is to test the safety of short course Daratumumab in combination with lenalidomide and to find out what effects, if any, short course Daratumumab in combination with lenalidomide has on people and their risk of multiple myeloma. The study is also designed to test the ...

Phase

6.15 miles

Learn More »

Study to Evaluate Safety PK PD Immunogenicity & Antitumor Activity of MSC-1 in Patients With Adv Solid Tumors

MSC-1 is a first-in-class, humanized monoclonal antibody (IgG1) which binds to the immunosuppressive human cytokine Leukemia Inhibitory Factor (LIF), and is intended to treat adult patients with advanced solid tumors. LIF is a pleiotropic cytokine involved in many physiological and pathological processes including the promotion of an immunosuppressive environment. In ...

Phase

6.15 miles

Learn More »

People with hepatocellular carcinoma are asked to participate in a research study being conducted by White Plains Hospital.

Phase N/A

7.27 miles

Learn More »

People with Non-squamous Non-small Cell Lung Cancer (NSCLC) may be eligible to participate in a research study being conducted by White Plains Hospital. IRB#18-06-116

Phase N/A

7.27 miles

Learn More »

The purpose of this study is to evaluate the safety and efficacy of two INCB050465 treatment regimens in participants diagnosed with relapsed or refractory marginal zone lymphoma (MZL) who are naive to or were previously treated with a Bruton's tyrosine kinase (BTK) inhibitor.

Phase

7.44 miles

Learn More »